08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
07.05.2014
- The UK could use its public interest powers to intervene in U.S. drugmaker Pfizer's potential takeover of British pharmaceutical firm AstraZeneca, Business Secretary Vince Cable...
05.05.2014
- U.S. drugmaker Pfizer increased its offer for the UK's AstraZeneca on May 2 to £63 billion ($106 billion) but the proposal, which would create the world's biggest pharmaceuticals...
05.05.2014
- With UK consumer health giant Reckitt having bowed out of the race to acquire the consumer business of U.S. drugmaker Merck & Co, Germany's Bayer is said to be in exclusive...
30.04.2014
- French pharmaceutical producer Sanofi is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, the news agency Reuters said, quoting...
29.04.2014
- Pfizer is now expected to increase its $100 billion offer to acquire UK rival AstraZeneca after being rebuffed a second time. The company has confirmed that it approached its...
29.04.2014
- Generics producer Actavis has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Israel's Teva to sell a generic version of Pfizer's...
28.04.2014
- Germany's Bayer and British consumer products giant Reckitt are said to have emerged as frontrunners to win the auction for the Merck & Co consumer products unit, each reportedly...
